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Factors influencing serum levels and peritoneal clearances of low
molecular weight proteins in continuous ambulatory peritoneal dialysis.
To identify the factors influencing the serum concentrations and the
peritoneal clearances of low molecular weight proteins (LMWP), fourteen
patients on continuous ambulatory peritoneal dialysis (CAPD) for 1 to 57
(mean 9.4) months were examined. LMWP [132-microglobulin (32m,
molecular wt 11.8 kD), cystatin C (cyst C, molecular wt 13.2 kD), Clara
cell protein (CC16, molecular wt 15.8 kD), retinol-binding protein (RBP,
molecular wt 21 kD) and alpha 1-microglobulin (a1m, molecular wt 33
kD)I and high molecular weight proteins (HMWP) [albumin (Aib, molec-
ular wt 66 kD), immunoglobulins (IgG, molecular wt 170 kD and 1gM,
molecular wt 600 kD) and alpha 2-macroglobulin (o2m, molecular wt 718
kD)I were determined by latex immunoassay in the serum and dialysate
collected during the peritoneal equilibration test (PET) with 2.27%
dextrose (N = 14), and in dialysate from 56 standard exchanges, per-
formed the day preceding PET, with 1.36% (N = 21), 2.27% (N = 23) and
3.86% (N = 12) dextrose. Determinants of serum concentrations and
transperitoneal clearances of the proteins were traced by stepwise regres-
sion analysis using as possible contributors age, sex, residual diuresis,
duration of the therapy (for serum concentrations), molecular radius of
the protein and peritoneal membrane characteristics (for peritoneal
clearances). LMWP serum concentrations were markedly increased
whereas serum concentrations of HMWP were within the normal range.
Residual diuresis, age and duration of dialysis emerged as significant
determinants of serum concentration of some proteins, whereas transperi-
toneal clearance was dependent mainly on the size of the protein and, only
for HMWP, on the dwell time. Residual diuresis was inversely related to
the serum concentrations of four LMWP. Age was negatively correlated to
the serum concentrations of f32m, CC16 and RBP. RBP and Alb were the
only proteins whose serum concentration significantly decreased with time
on CAPD. The relationship between peritoneal clearance and Mr shows
two slopes suggesting the existence of two populations of pores in the
peritoneal capillary wall: small pores of about 20 to 25 A radius and large
pores exceeding 100 A radius. A long dialysis cycle is associated with
significant loss of HMWP only. Daily peritoneal protein losses, in mg
(mean Sn), were as follows: J32m 43.4 4.5; cyst C 9.6 1.8; CC16 1.8
0.3; RBP 58.9 11.1; u1m 149.5 15.7; AIb 6570 530; IgG 750
111; 1gM 46.4 14.9; and a2m 67.0 12.7. In conclusion, LMWP
concentrations in the serum of patients on CAPD were markedly in-
creased and influenced mainly by patient-related factors (residual diuresis
and age). Serum albumin and RBP declined with the duration of dialysis.
Peritoneal protein loss was determined by the size of the protein and, for
large proteins, by the dwell time. The peritoneum behaves as a membrane
with at least two populations of pores.
The class of low molecular weight proteins (LMWP) includes a
great variety of proteins with different biological functions. These
proteins are characterized by their small size (<40 kD) leading to
their rapid elimination from plasma by glomerular filtration and
subsequent catabolism in proximal tubular cells. Recently, we
demonstrated that (1) their serum concentration was elevated in
hemodialyzed patients, and (2) the determinants of the pre-
dialysis serum level are patient-related (residual diuresis, age and
sex), whereas those of the dialysis induced change in serum
concentration are related to the protein size, permeability of the
dialysis membrane and the degree of hemoconcentration [1].
Similar data are not available in patients who are on peritoneal
dialysis. Available information is limited to the loss and the
peritoneal transport characteristics of 132m, high molecular weight
proteins (HMWP) such as albumin, immunoglobulins, comple-
ment metabolites, and to the peritoneal transport characteristics
of neutral dextrans [2—7]. In the present study we determined the
serum concentrations and the peritoneal losses of five LMWP
[/32-microglobulin (2m, molecular wt 11.8 kD), cystatin C (cyst C,
molecular wt 13.2 kD), protein 1 or Clara cell protein (CC16,
molecular wt 15.8 kD), retinol-binding protein (RBP, molecular
wt 21 kD) and alpha 1-microglobulin (a1m, molecular wt 33 kD)]
and four HMWP [albumin (Aib, molecular wt 66 kD), immuno-
globulins (IgG, molecular wt 170 kD; 1gM, molecular wt 600 kD)
and alpha 2-macroglobulin (a2m, molecular wt 718 kD)] in
patients who were on continuous ambulatory peritoneal dialysis
(CAPD). The factors influencing these parameters were also
examined. The results demonstrate a marked elevation of the
serum concentrations of LMWP in patients on CAPD, which is
similar to that reported for hemodialyzed patients [1]. These
serum levels are determined by patient-related factors (residual
diuresis and age) and, only for albumin and RBP, related to the
duration of dialysis. Peritoneal clearance of individual proteins is
a function of their size.
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Methods
Patients
Fourteen patients (6 females and 8 males) with a mean (± SD)
age of 52.5 13.6 (females) and 51.0 12.9 (males) years,
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Table 1. Patient characteristics
Patient
no. Sex
Age
yr
Weight
kg
Dialysis
duration
months Diagnosis
Residual
diuresis
m1124 hr
1.
2.
3.
m
m
m
64
26
46
65.0
70.4
71.5
57
8
7
Amylosis
Ig A GN
Sarcoidosis
0
0
135
4.
5.
m
w
56
59
59.6
59.2
14
1
Wegener
HTA
450
1180
6. w 70 57.8 18 CIN 420
7. w 47 50.5 9 Diabetes 400
8. m 52 67.5 3 MPGN 140
9. m 57 68.1 1 CGN 160
10. w 33 54.8 3 CIN 1300
11. w 44 69.9 1 PKD 0
12. w 62 37.5 5 HTA 0
13. m 42 62.5 2 HTA 125
14. m 65 70.1 3 Diabetes 400
Abbreviations are: IgA GN, IgA glomerulonephritis; PKD, polycystic
kidney disease; HTA, hypertension; CIN, chronic interstitial nephritis;
MPGN, membranoproliferative glomerulonephritis; CGN, crescentic gb-
merulonephritis.
undergoing CAPD for 1 to 57 (mean 9.4) months were included.
Their clinical characteristics, primary kidney disease and residual
diuresis are presented in Table 1. At the time of the study, none
had nephrotic syndrome or other pathological conditions such as
chronic liver or lung disease, malignancy or inflammatory disor-
ders, likely to interfere with protein metabolism. All patients had
been free from peritonitis for at least one month prior to the
study.
Dialysis procedure
The CAPD catheters were of the straight Missouri swan-neck
type. They were surgically inserted through an infra-umbilical
midline incision, with the exit-site about 6 cm above and 30
degrees off center from the original incision.
Patients were dialyzed continuously with four exchanges daily
(3 in the daytime, 1 overnight), with 2 liters of dialysate containing
1.36%, 2.27% or 3.86% dextrose (Baxter Healthcare, Round
Lake, IL, USA). The dwell time ranged from 3 to 6 (mean 4.45)
hours during daytime and 9 to 12 (mean 10.50) hours during
overnight exchanges. For the latter, only a 1.36% dextrose solu-
tion was used. The total dialysate effluent volume was recorded
for all cycles of varying dwell time.
The recommended daily protein intake was 1.2 to 1.5 g/kg of
body wt. Diet was supplemented whenever necessary with vita-
mins, calcium carbonate and aluminium hydroxide.
Study protocol
Samples were obtained during a standard four-hour peritoneal
equilibration test (PET) [8], with 2.27% dextrose (N = 14). Serum
samples were drawn at two hours, samples of dialysate were taken
at the end of inflow and after two and four hours of PET. The
total effluent volume was recorded at the end of the test. During
the 24 hours preceding the PET, additional samples were ob-
tained from each drained exchange whose volume was measured
[N = 56, including 1.36% (N = 21), 2.27% (N = 23) and 3.86%(N = 12) dextrose]. All samples were frozen at —20°C until the
day of analysis.
Analytical methods
All the proteins were determined in serum and dialysate
samples by a sensitive immunoassay relying on the agglutination
of latex particles (latex immunoassay) [9], using the antibodies
from Dakopatts (Glostrup, Denmark). Creatinine was measured
in serum and dialysate by the Jaffé's technique; dialysate values
were corrected for glucose concentration, as previously described
[81. Urea nitrogen was measured by a modified carbamido-
diacetyl reaction (Technicon SMAC System). Serum and dialysate
glucose concentrations were determined by oxidation using the
Beckman Glucose Analyzer 2.
Calculations and statistical analysis
PET data. Peritoneal mass transfer (PMT, mg/4 hr) and pen-
toneal clearance (Cl, mb/mm) of creatinine, urea and of proteins
were calculated from PET data as follows: Ve CC/T and Ve C/t
• P, respectively, where: V = total dialysate effluent volume (ml),
C = dialysate effluent concentration of solute or protein, T and
= dwell time in hours and minutes, respectively, and P = serum
concentration of the solute or protein [10]. Cl and PMT data were
normalized for the body surface area (BSA) of 1.73 m2 and
expressed as the arithmetic mean SE.
Log transformation of the data were used if necessary (abnor-
mal distribution) before statistical analysis. Factors influencing
the serum levels or peritoneal loss of the proteins were analyzed
by stepwise regression analysis using as dependent variable the log
of the serum concentration or of the peritoneal clearance of the
proteins, and as independent variables age, sex, residual diuresis
as an indirect marker of residual glomerular filtration rate,
duration of the therapy (for serum levels), molecular radius (Mr)
of the protein (for penitoneal clearances) and peritoneal mem-
brane characteristics. Sex was introduced in the model categorized
as female 0 and male 1. Peritoneal membrane characteristics were
determined on the basis of the PET results [8] and categorized as
low 0 (N = 2), low-average 1 (N = 6), high-average 2 (N = 4) and
high 3 (N = 2) permeable membrane.
Dialysate data
Daily loss of each protein (mg) was calculated from the protein
concentration and the measured effluent volume of the exchanges
collected during the 24 hours preceding PET. The influence of
dextrose concentration and dwell time on the loss of proteins was
evaluated in patients with low average and high average perito-
neal permeability characteristics (N 10), excluding those with
either high or low peritoneal permeability (N = 4).
The influence of dextrose levels was examined by comparing the
protein loss during a five-hour two liter exchange with 1.36% (N
= 8), 2.27% (N = 12) and 3.86% (N = 8) dextrose. The influence
of dwell time was assessed by comparing creatinine and protein
peritoneal loss during short (5 hr, N = 8) and long (10 hr, N = 10)
time exchange with two liters of 1.36% dextrose. All these samples
were obtained from the exchanges performed the day preceding
PET. Comparisons between the groups were performed by anal-
ysis of variance followed by the Scheffé's multiple comparison test,
or by multiple linear regression analysis with P <0.05 considered
as statistically significant.
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Table 2. Serum concentrations, peritoneal mass transfer, clearances and daily loss of solute and proteins (mean SE) in patients on
CAPD (N = 14)
Serum Peritoneal mass Peritoneal
Mr concentration, transfer clearance
Parameters A mg/liter mg/4 hr 1.73 m2 p2/mm 1.73 m2
Daily
peritoneal loss
mg
Urea 2.6 1272 48 267.6 15.8 15,100 500 —
Creatinine 4.0 97.1 3.5 98.7 6.0 7,600 500 —
LMWP
cyst C 15.1 8.8 0.4 2.0 0.3 1559 126 9.6 1.8
16.0 33.4 1.3 10.5 1.5 1330 165 43.4 4.5
CC16 19.0 2.8 0.2 0.4 0.1 656 110 1.8 0.3
RBP 17.5 260.1 12.5 14.2 3.6 459 56 58.9 11.1
a1m 27.7 508.9 25.4 40.4 7.8 168 33 149.5 15.7
HMWP
Albumin 36.0 37,100 500 1657 277 190 33 6570 530
IgG 54.0 12,700 900 141.3 16.1 65 17 750 111
o2M 89.0 2526 166 13.1 2.2 35 10 67.0 12.7
1gM 96.0 1629 204 8.4 2.4 22 3 46.4 14.9
Abbreviations are: Mr, molecular radius; LMWP, low molecular weight proteins; HMWP, high molecular weight proteins.
Normal range in serum, LMWP (mg/liter): cyst C, 0.6—1.6; 2m, 1—2; CCI6, 0.05—0.1; RBP, 50—80 and a1m, 20—100; HMWP ( g/liter): AIb, 35—50;
IgG 5—14; a2m, 1.5—3.5 and 1gM, 0.6—2.5.
Results
Serum levels
The serum concentrations of LMWP were markedly increased,
with mean values 4 to 40 times above normal; those of HMWP
were within the normal range (Table 2).
Peritoneal transfer characteristics
The dialysate over serum concentration ratios observed for
proteins and solutes at two and four hours during the PET are
depicted in Figure 1. It is noteworthy that it increased continu-
ously over time, a trend towards equilibrium being observed only
for urea. The ratio at four hours decreased as Mr increased (Fig.
1).
The peritoneal clearances and the peritoneal mass transfer of
solutes and proteins during the four hours PET are given in Table
2.
Peritoneal loss of proteins
The daily loss of proteins calculated on the basis of protein
concentrations and drained volume of each exchange collected
during the 24 hours preceding the PET is described in Table 2. It
ranges (mean SE) from 1.8 0.3 (CCI6) to 149.5 15.7 (a1m)
mg for LMWP and 46.4 14.9 (1gM) to 6,570 530 (Alb) mg for
HMWP.
Determinants of serum levels and peritoneal transport of
the proteins
Serum levels. Residual diuresis was inversely related to the
serum concentrations of the four LMWP. It emerged as the most
important determinant of the serum LMWP concentration. Age
was inversely related to the serum concentrations of /32m, CC1 6
and RBP. RBP and AIb were the only proteins whose serum
concentration significantly decreased with time on peritoneal
dialysis. Other factors such as peritoneal membrane characteris-
tics and sex were without influence on the protein serum levels
(Table 3).
Peritoneal transport. The peritoneal transport of proteins is
influenced by the M of the protein. Indeed, by stepwise regres-
sion analysis using clearance data of all proteins as dependent
variable and age, sex, residual renal function, duration of therapy,
Mr of the protein and peritoneal membrane characteristics as
possible predictors, only M emerges as significant determinant
(inversely related to the peritoneal clearance, r2 = 0.54, P =
0.0001). The relationship between peritoneal clearance and Mr
shows a hyperbolic regression, constituted by two slopes [(a) y =
5.646 — 2.728x, r2 = 0.86, P = 0.0001; (b) y = 0.238 to 0.023x, r2
= 0.85, P = 0.0001), suggesting the existence of two different
populations of pores, a small one allowing proteins with Mr < 25
A and another much larger accommodating proteins with Mr
above 25 A radius (Fig. 2).
The influence of dialysate dextrose concentration on protein
loss is assessed during five hours exchanges. Results, presented in
Figure 3, demonstrate that protein losses are virtually identical for
each of three tested dextrose concentrations (1.36%, 2.27% and
3.86%), although the ultrafiltrate volume proved significantly
higher for 3.86% than for 1.36% dialysate (results not shown).
The influence of dwell time was assessed by the ratio of protein
loss at 10 over that of the five hour dwell with 1.36% dextrose
dialysate. The average drained volume was identical for the two
dwell times (2020 540 ml during 10 hr and 2045 750 ml during
5 hr dwell exchange). As shown in Figure 4, the ratio increases
with the Mr of the protein, the difference with the creatinine ratio
reaching significance for albumin and other larger HMWP.
Discussion
Our results demonstrate that, in CAPD patients, LMWP serum
concentrations are markedly elevated, within the range reported
previously in hemodialyzed patients [1J, whereas serum concen-
trations of all large proteins are within the normal range. Taking
into account the biological activities of some of these LMWP,
such as 2m, CC16 and cyst C [11—16], it is suggested that their
Kabanda et a!: LMWP in CAPD 1949
Cyst C 2m RBP CC16 a1m
AIb lgG ca2m lgM
Proteins
retention contributes to the uremic syndrome of patients on
CAPD.
The serum concentrations of LMWP in long-term CAPD
patients are significantly influenced by residual renal function.
Residual diuresis, used as a surrogate of residual renal function
[17], is indeed inversely correlated with all LMWP serum levels,
Taken together with similar observations made in patients given
hemodialysis [1], these results confirm the major role of the
residual kidney function in the catabolism of LMWP. Our results
are in agreement with those obtained by others for 132m in CAPD
patients [18—20].
Advancing age is associated with a progressive fall of the serum
concentrations of 132m, CC16 and RBP. This observation is of
special interest for f32m, since age is considered a risk factor in the
Partial
Dependent
variable Independent variables
regression
coefficient
Partial
r2
f32m Age
Sex
Residual diuresis
Duration of therapy
Peritoneum characteristics
—0.267
0.03 1
—0.0012
—0.008
0.22
0.lla
0.03
0.37"
0.05
0.06
Cyst C Age
Sex
Residual diuresis
Duration of therapy
Peritoneum characteristics
—0.271
0.123
—0.0003
—0.0021
0.30
0.04
0.06
030"
0.06
0.04
CC16 Age
Sex
Residual diuresis
Duration of therapy
Peritoneum characteristics
—0.589
—0.11
—0.0003
0.21
—0.03
0.09
0.06
0.29"
0.01
0.004
RBP Age
Sex
Residual diuresis
Duration of therapy
Peritoneum characteristics
—0.219
0.188
—0.0002
—0.062
—0.03
0.16'
0.03
0.10
0.39"
0.01
Aib Age
Sex
Residual diuresis
Duration of therapy
Peritoneum characteristics
—0.070
0.035
0.0002
—0.002
0.30
0.04
0.05
0.02
0.32"
0.06
development of f32m amyloidosis in dialyzed patients [21]. De-
creased serum levels in aged patients could reflect an enhanced
removal of 2m into synovial amyloid deposits. Alternatively it
may result from a decreasing synthesis of LMWP. The latter
hypothesis, unlike the former, also accounts for the effect of age
on the serum level of the other LMWP whose precipitation has
never been documented in dialyzed patients.
In contrast to the observations made in hemodialyzed patients
I
Table 3. Determinants of serum LMWP and albumin (Aib) in CAPD
patients (N 14)
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Fig. 1. Equilibration between dialysate and plasma, expressed as % of
dialysate to plasma concentration ratios (DIP), for creatinine, urea and
proteins during peritoneal equilibration test (N = 14). Symbols are (U) the
first two hours and () the following two hours of PET. Note the
differences in scale for the three parts of the Figure.
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Fig. 2. Transperitoneal protein clearances (mIlminIl. 73 m2 BSA) as a
fsnction of molecular radius (A) of the proteins. Symbols are: (0) low
molecular weight proteins; (•) alphal-microglobulin and high molecular
weight proteins.
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Fig. 3. Protein losses during five hours dwell with 1.36%, 2.27% and 3.86%
dextrose. Symbols are: (•) Clara cell protein; () cystatin C; ()
132-microglobulin; () retinol-binding protein; (LI) alpha 1-microglobulin;() 1gM; () alpha 2-microglobulin; () IgG; and () albumin.
[1], serum RBP and AIb significantly decrease in patients on
long-term peritoneal dialysis. Interestingly, these two proteins are
synthesized mainly by the liver. Peritoneal losses of RBP and AIb
might therefore exceed their synthesis by the liver. Whether RBP
is—despite its elevated level—like albumin, a good indicator of the
nutritional status in peritoneal dialysis patients remains to be
demonstrated. These data have to be taken with caution since
duration of therapy with CAPD did not exceed 12 months in the
majority of our patients.
Protein loss into dialysate is a major drawback with peritoneal
dialysis [2—7]. It may indirectly contribute to various nutritional
and metabolic disturbances in patients on CAPD such as hyper-
cholesterolemia or altered amino acid metabolism [221.Our study
not only confirms the important daily losses of HMWP, but
quantifies for the first time the daily losses of specific LMWP such
as RBP, cyst C, CC16 and a1m in peritoneal dialysis. The
peritoneal transport of the proteins being related to their serum
concentrations and to the dwell time (mainly for HMWP), the
comparison of results between different studies requires that
patients should be matched for these determinants. However that
may be, the values of daily protein losses observed by us are within
the range reported in the literature for albumin or other large
proteins [2, 3, 6] and f32m [18—20].
Peritoneal transport of the various proteins is significantly
related to their molecular radius: the higher the radius, the lower
the peritoneal clearance. This finding is in agreement with those
made previously by others [6, 7, 10, 23], who mainly used larger
proteins or dextrans. We extend this concept by relying on a larger
range of LMWP. The use of representative proteins of the LMWP
class [Mr from 15.1 (cyst C) to 27.7 A (a1m)] in addition to
HMWP [Mr from 36.0 (Alb) to 96.0 A (1gM)] allows an analysis
of the peritoneal membrane characteristics. Our results suggest
the existence of at least two populations of pores in the peritoneal
capillary walls. As illustrated in the Figure 2, the relationship
between peritoneal clearance and molecular radii exhibits two
slopes. The first slope suggests the presence of small pores of
about 20 to 25 A radius through which LMWP with a Mr < 25 A
diffuse. The second slope is compatible with the existence of
larger pores exceeding 100 A radius, through which proteins with
Mr above 25 A radius are cleared. This observation fits the
two-pore theory for transcapillary transport of the proteins [24—
26]. In the peritoneal capillary wall, Nakamura and Wayland [24]
have suggested the existence of small pores of approximately 30 A
radius and larger pores exceeding 150 A radius. Rippe and Stelin
[27], using a computer simulation, report a large number of small
pores in the 40 to 50 A range, and a small number of larger pores
in the 200 to 300 A range. Imholz et al [28] propose a radius of less
than 40 A for the small pores. None of these three studies
evaluates the peritoneal handling of proteins with a Mr in the
critical 16 to 35 A range. In our study, the availability of three
LMWP in the latter range provides a better definition of the
smaller pore sizes. Of special interest is the observation that u1m,
although classified among LMWP, behaves as a HMWP as a
result of its Mr (27.7 A), just above the proposed size of the small
pores.
The presence of a third ultrasmall pore (<5 A) that is only
involved in fluid transport has been postulated [29]. Its existence
could not be tested with the proteins evaluated in the study.
Although an increased transcapillary ultrafiltration induced by
hypertonic dialysate (3.86%) during the first hour dwell might
influence the convection of macromolecules [30], we were unable
to detect any influence of dextrose concentration on the loss of the
various tested proteins after a five hour dwell. Similar observa-
tions were made by others on the loss of small solutes and total
protein after a six hour dwell [31, 32] or HMWP during the
overnight or daytime exchanges [6]. Imholz et al [28] evaluated
the effect of dialysate tonicity on the peritoneal clearance rather
than on the mass transfer of proteins. Raising dextrose concen-
tration from 1.36% to 3.86% did not modify the clearance of
HMWP but was associated with a small, but significant increase of
132n1 clearance for 1.17 to 1.34 mI/mm.
Dwell time also influences transperitoneal transport of proteins
but the effect is significant only for HMWP. Indeed, the protein
loss ratio of 10 over a five hour exchange indicates that the loss of
large proteins, such as albumin, immunoglobulins and alpha
2-macroglobulin, increases when dwell time is extended. In con-
trast, dwell time influences LMWP removal to a smaller but not
statistically significant extent. Comparing peritoneal protein loss
between short (4 hr) and long (8 hr) cycles, Kagan et al [10] also
found that LMWP and small solutes clearances were unchanged
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Fig. 4. Concentration ratios of creatinine and
protein losses at 10 over a five hour dwell with
dextrose 1.36% as a function of molecular radius.
Symbols are: (LII) creatinine; ([Ii) cystatin C; ()
/32-microglobulin; (III) retinal-binding protein;() Clara cell protein; () alpha
i-microglobulin; (•) albumin; () IgG; ()
alpha 2-macroglobulin; and () 1gM.
*Statistically significant compared to creatinine.
or decreased, while they are significantly increased during the long
cycle for Alb, IgG and 1gM.
Other factors such as residual renal function, age, sex and
dialysis duration do not influence the peritoneal transport of the
proteins. The peritoneal membrane characteristics, assessed on
the basis of the PET results, apparently fail to influence the
protein peritoneal transport, a finding to be interpreted with
caution as the number of patients included in the extreme groups
is small.
From this study, we conclude that in CAPD patients serum
LMWP concentrations are markedly increased. Their level is
influenced mainly by patient-related factors (residual diuresis and
age). Serum albumin and RBP are the only proteins where the
concentration is inversely related to duration of dialysis. Proteins
are lost through the peritoneum according to their molecular
radius. It may be inferred from this relationship that the perito-
neal membrane behaves like a two-pore model in the handling of
proteins. The fact that extending the dwell time to 10 hours
influences only the loss of HMWP equal to or larger than albumin
suggests that substitution of short cycle to long cycle dialysis might
reduce the loss of HMWP without affecting the clearance of small
and middle size molecules.
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